Catalyst Wire Dossier Catalyst Wire Dossier

Vincristine sulfate liposome injection

vincristine sulfate liposome injection · Nanjing Luye Sike Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vincristine sulfate liposome injection, covering 2014-03-03 to 2023-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma [Phase 1]

See pricing